[192 Pages Report] The Hemostats & Tissue Sealants Market size was estimated at USD 10.50 billion in 2023 and expected to reach USD 11.78 billion in 2024, at a CAGR 12.33% to reach USD 23.72 billion by 2030.
Hemostats & tissue sealants are used in several surgical disciplines to stop bleeding mechanically or by augmenting the coagulation cascade. Tissue sealants are products that bind to and close cuts in tissue. The increasing aging population, the rising prevalence of chronic conditions and diseases, and the need for timely surgeries are expected to drive the market’s growth. Several government initiatives to focus on wound closure management and easy availability of hemostats & tissue sealants are the market growth factors. However, the higher cost of surgical procedures, the rising prices of surgical products and treatments, and strict regulations regarding the utilization of hemostats & tissue sealants hamper the market growth. Technological advancement in hemostats & tissue sealants products and increasing use of biopolymer-based hemostats are expected to create a significant market opportunity in the forecasted period.
Regional Insights
The Americas has a significant presence in the hemostats & tissue sealants market owing to the growing prevalence of cardiovascular diseases, diabetes, and cancer and increasing health expenditure within the region. According to the National Health Expenditure Accounts, U.S. healthcare spending increased by 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person to address rising healthcare issues. The launch of advanced and innovative products, the rising number of surgeries, and the increasing demand for more effective and quicker healing post-surgery are enhancing the demand for hemostats & tissue sealants in the European region. The proliferating approvals and clearance of hemostats & tissue sealants have expanded the availability of new products in Europe. The hemostats & tissue sealants market is growing in Asia-Pacific due to increased medical tourism and surgical procedures volume.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Hemostats & Tissue Sealants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats & Tissue Sealants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katg?t Sanayi ve Tic. A.?., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.
Market Segmentation & Coverage
This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product Type
- Hemostats
- Active Hemostats
- Flowable Hemostats
- Mechanical Hemostats
- Tissue sealants
- Fibrin Sealants
- Synthetic Sealants
- Hemostats
- Application
- Burn & Trauma Cases
- Cardiovascular
- General Surgeries
- Neurological
- Orthopedic
- Reconstructive Surgeries
- Urological
- End User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Hemostats & Tissue Sealants Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats & Tissue Sealants Market?
- What are the technology trends and regulatory frameworks in the Hemostats & Tissue Sealants Market?
- What is the market share of the leading vendors in the Hemostats & Tissue Sealants Market?
- Which modes and strategic moves are suitable for entering the Hemostats & Tissue Sealants Market?
US $
Euro €
GBP £
